Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

VETBIOMAT

Financiado

Cerrado

Advanced material for the regeneration of joints in veterinary medicine

The main objective of VetBiomat is to undertake a technical and market feasibility study on an innovative regenerative medicine treatment for osteoarthritis (OA) in horses and dogs based on a new advanced material, HR007. The use... ver más

31/07/2015

ARTINVET INNOVATIV...

71K€

Presupuesto del proyecto: 71K€

Líder del proyecto

ARTINVET INNOVATIVE THERAPIES El desarrollo, investigación y comercialización de toda clase de medicamentos

TRL 4-5 | 50K€

Fecha límite participación Sin fecha límite de participación.

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2015-07-31

NMP-25-2014-1: Accelerating the uptake of nanotech...

I+D

Cerrada hace 10 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

2 Participantes

ARTINVET INNOVATIVE THERAPIE...

50.00K€ | Lider

MADERAS SIERO

670.61K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

ReZone Regulation of Articular Cartilage Zonal Emergence: Harnessi... 2M€ Cerrado

GAMBA Gene Activated Matrices for Bone and Cartilage Regeneration... 4M€ Cerrado

ArthroDUR Bifunctional and regeneratively active biomaterial Towards... 150K€ Cerrado

ANCHOR Articular cartilage regeneration through the recruitment of... 150K€ Cerrado

RECoil3D Dynamic coil shaped polylactic acid reinforced extracellular... 181K€ Cerrado

EQC2018-005046-P UNIDAD EXPERIMENTAL DE TERAPIA REGENERATIVA EN PATOLOGÍAS OS... 292K€ Cerrado

Duración del proyecto: 6 meses Fecha Inicio: 2015-01-13
Fecha Fin: 2015-07-31

Líder del proyecto

ARTINVET INNOVATIVE THERAPIES El desarrollo, investigación y comercialización de toda clase de medicamentos

TRL 4-5 | 50K€

Presupuesto del proyecto 71K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The main objective of VetBiomat is to undertake a technical and market feasibility study on an innovative regenerative medicine treatment for osteoarthritis (OA) in horses and dogs based on a new advanced material, HR007. The use of this material is expected to significantly increase treatment efficiency over currently marketed products and address the unmet need of achieving a cure for this disease in horses and dogs. Osteoarthritis, a progressive deterioration of the joint cartilage, is a major economic problem in veterinary medicine. Currently, there is no cure for OA, and therapies available rely on reducing symptoms (corticosteroids, NSAIDs, and analgesics) or on the administration of glycosaminoglycans by different routes. No sound scientific evidence of efficacy for most glycosaminoglycans based commercial treatments has yet been obtained, especially when administered orally, nutraceuticals, which actually have the largest market share. Therefore, the market potential for a new efficacious, complex, and regenerative intra-articular product of non-bovine origin is very large. ArtinVet Innovative Therapies, S.L., a new SME specialized in veterinary regenerative medicine, has a novel and unique multiple GAGs rich material of natural origin, HR007, for inclusion in new regenerative medicine based products for veterinary medicine. This advanced material has shown in vitro superior qualities to any other tested products in promoting cartilage regeneration and chondrocytes and mesenchymal cells migration. HR007 production has been standardized and industrialized. Successful completion of Phase 1 of VetBiomat will yield a robust business plan for a much larger project that will seek funding under Phase 2 of the SEM Instrument, when clinical studies and product authorization procedures will be accomplished. Successful accomplishment of phases 1 and 2 will be essential for accelerating the growth of the SME ArtinVet and its international market positioning.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores